SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CORRESP - Correspondence:
SEC Accession No. 0001437749-18-002121
Filing Date
2018-02-09
Accepted
2018-02-09 09:53:30
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 28611
2 image1.jpg GRAPHIC 3098
  Complete submission text file 0001437749-18-002121.txt   34210
Mailing Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Aviragen Therapeutics, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)